BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17921728)

  • 1. High-dose external beam radiation for localized prostate cancer: current status and future challenges.
    Nguyen PL; Zietman AL
    Cancer J; 2007; 13(5):295-301. PubMed ID: 17921728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on radiation therapy in prostate cancer.
    Lee AK; Frank SJ
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):857-78. PubMed ID: 16861119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of outcome of prostate cancer (TCP, NTCP).
    Perez CA; Michalski J; Mansur D
    Rays; 2005; 30(2):109-20. PubMed ID: 16294903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
    Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
    Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External beam radiotherapy for prostate cancer: current position and trends.
    Koukourakis MI; Touloupidis S
    Anticancer Res; 2006; 26(1B):485-94. PubMed ID: 16739309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-beam therapy for prostate cancer.
    Kagan AR; Schulz RJ
    Cancer J; 2010; 16(5):405-9. PubMed ID: 20890135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External beam irradiation for localized prostate cancer--the promise of hypofractionation.
    Loblaw DA; Cheung P
    Can J Urol; 2006 Feb; 13 Suppl 1():62-6. PubMed ID: 16526985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer.
    Efstathiou JA; Trofimov AV; Zietman AL
    Cancer J; 2009; 15(4):312-8. PubMed ID: 19672148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer.
    Hurwitz MD
    Nat Clin Pract Oncol; 2008 Nov; 5(11):668-76. PubMed ID: 18825143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
    Kaidar-Person O; Roach M; Créhange G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conformal radiation therapy with or without intensity modulation in the treatment of localized prostate cancer].
    Maingon P; Bolla M; Truc G; Bosset M; Peignaux K; Ammor A
    Cancer Radiother; 2005 Nov; 9(6-7):382-7. PubMed ID: 16095944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy.
    Yoshimura K; Kamoto T; Nakamura E; Segawa T; Kamba T; Takahashi T; Nishiyama H; Ito N; Takayama K; Mizowaki T; Mitsumori M; Hiraoka M; Ogawa O
    Prostate Cancer Prostatic Dis; 2007; 10(3):288-92. PubMed ID: 17160068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.